Cyproheptadine Hydrochloride Syrup
Subpotency: product assayed and found OOS for cyproheptadine
Class III means the product is unlikely to cause harm but violates FDA labeling or manufacturing rules. These are the recalls you rarely hear about; pharmacies usually just swap the affected lot.
1,716 recalls, newest first.
Subpotency: product assayed and found OOS for cyproheptadine
Failed impurities/degradation: out of specification result for impurity secorapamycin.
Crystallization; complaints received by the manufacturer of crystals forming in product
Failed Impurities/Degradation Specifications: Out of specification results for unknown impurity.
CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.
Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.
Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.
Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above currently approved specification levels.
Crystallization; Complaints that cream appears to have crystallized
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Labeling: Incorrect or Missing Package Insert
Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.
Failed Impurities/Degradation Specification; 9 month stability
Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
Failed Tablet/Capsule Specifications
cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Defective delivery system: Softgel capsules are leaking.
Lack of Assurance of Sterility
Chemical Contamination: Bottles may contain broken dessicants